Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 10:04 PM
Study NCT ID:
NCT02063958
Status:
COMPLETED
Last Update Posted:
2018-07-30
First Post:
2014-02-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors
Sponsor:
Esanex Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-20
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-13
First Submit QC Date:
None
Study First Post Date:
2014-02-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-26
Last Update Post Date:
2018-07-30
Last Update Post Date Type:
ACTUAL